MICROPAKINE L.P. 250 mg, granules with extended release in a single-dose sachet 30 sachets
Active ingredients: Valproic acid, Sodium valproate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Granules with extended release30 sachetsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- MICROPAKINE L.P. 250 mg, granulés à libération prolongée en sachet-dose
- Pharmaceutical form
- granulés à libération prolongée
- Route of administration
- orale
- Presentation description
- 30 sachet(s)-dose(s) papier aluminium complexe résine(s) ionomère
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 May 2005
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
67369481CIP73655121CIP133400936551213Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALPROATE DE SODIUMgranulés | 166,76 mg · un sachet-dose | SA |
| ACIDE VALPROÏQUEgranulés | 72,61 mg · un sachet-dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.